Replies to post #402227 on Anavex Life Sciences Corp (AVXL)

[BIOChecker4]

If the Anavex story had any validity, then Missling, together with a top investment bank or banks, would be able to put together an “A” list of biotech institutional investors to finance the company long term and give it credibility where today it has precious little. All Anavex would need is a few bellwether investor names (firms like Perception Life Sciences, Janus Life Sciences Fund, and Biotechnology Value Fund) and we’d truly be on our way. The Street’s perception of Anavex would do a 180, from third-tier curiosity to serious player. Likewise, healthcare/business reporters at major news organizations would suddenly take an interest and bring the Anavex story to a much wider audience. Ditto for potential partners.